^
    No biomarker
    Osteosarcoma
    doxorubicin hydrochloride
    Sensitive
    :
    A1
    No biomarker
    Osteosarcoma
    ADX-2191
    Sensitive
    :
    A1
    No biomarker
    Osteosarcoma
    regorafenib
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    IE
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    regorafenib + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    sorafenib + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + etoposide IV + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    etoposide IV + cyclophosphamide oral
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel + ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + ifosfamide + etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + ifosfamide + methotrexate + SGN-15
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + ifosfamide + pegylated liposomal doxorubicin
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    ifosfamide + etoposide oral + methotrexate
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    sorafenib + everolimus
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    topotecan + cyclophosphamide intravenous
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cabozantinib tablet
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    sorafenib
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + SGN-15 + methotrexate IV
    Sensitive
    :
    A2
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES